SCHEMBL20663166

SCHEMBL20663166

O=C(OCc1ccccc1)c1cc(Cl)nc2[nH]ncc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 5/20 0.48
POLB P06746 1/20 0.48
CCNB2 O95067 1/20 0.46
CCNE2 O96020 1/20 0.46
CDK1 P06493 1/20 0.46
CCNB1 P14635 1/20 0.46
CCNE1 P24864 1/20 0.46
CDK2 P24941 1/20 0.46
CCNB3 Q8WWL7 1/20 0.46
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 3/20 0.46
TDP1 Q9NUW8 3/20 0.45
HPGD P15428 2/20 0.44
P2RX7 Q99572 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
GCGR P47871 1/20 0.43
TSHR P16473 1/20 0.43
CASP3 P42574 1/20 0.43
RAB9A P51151 1/20 0.43
SENP8 Q96LD8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29904837 0.82 ALDH1A1 (0.50) DHODHCCNE1CDK2KDM4EALDH1A1
SCHEMBL14760220 0.82 ALDH1A1 (0.50) DHODHCCNE1CDK2KDM4EALDH1A1
SCHEMBL1902851 0.79 KDM4E (0.68) DHODHPOLBKDM4EALDH1A1TDP1
SCHEMBL16343486 0.76 DHODH (0.47) DHODHPOLBKDM4EALDH1A1TDP1
SCHEMBL18529536 0.74 PLK4 (0.55) POLBCCNB2CCNE2CDK1CCNB1
SCHEMBL8604469 0.74 POLB (0.58) DHODHPOLBALDH1A1TDP1L3MBTL1
SCHEMBL26322070 0.73 ALDH1A1 (0.46) POLBALDH1A1TDP1L3MBTL1TSHR
SCHEMBL25683007 0.73 ALDH1A1 (0.46) DHODHPOLBALDH1A1TDP1P2RX7
SCHEMBL14769542 0.73 PLK4 (0.40) KDM4EALDH1A1RAB9AMAPT
SCHEMBL17730705 0.72 ALDH1A1 (0.61) POLBKDM4EALDH1A1TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2791137-B1 PYRAZOLOPYRIDINE DERIVATIVES, PREPARATION PROCESS THEREFOR AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2019-01-23 EP disclosed